Analysis of a novel AVPR2 mutation in a family with nephrogenic diabetes insipidus

International Journal of Clinical and Experimental Medicine

Volumn 4, Issue 1, 2011, Pages 1-9

  Moon, Sung Dae ^a   Kim, Ju Hee ^a   Shim, Joo Yun ^a   Lim, Dong Jun ^b   Cha, Bong Yun ^b   Han, Je Ho ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Avpr2; Frameshift mutation; Nephrogenic diabetes insipidus; Vasopression

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR 2; CYCLIC AMP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EXPRESSION VECTOR; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KOREA; MALE; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; WILD TYPE;

EID: 79951717181     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M and Bichet DG. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992; 359: 233-235.
2. Boson WL, Della Manna T, Damiani D, Miranda DM, Gadelha MR, Liberman B, Correa H, Romano-Silva MA, Friedman E, Silva FF, Ribeiro PA and De Marco L. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients. Genet Test 2006; 10: 157-162.
3. Tsukaguchi H, Matsubara H, Taketani S, Mori Y, Seido T and Inada M. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest 1995; 96: 2043-2050.
4. Chen CH, Chen WY, Liu HL, Liu TT, Tsou AP, Lin CY, Chao T, Qi Y and Hsiao KJ. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients. J Hum Genet 2002; 47: 66-73.
5. Hoekstra JA, van Lieburg AF, Monnens LA, Hulstijn- Dirkmaat GM and Knoers VV. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 1996; 61: 81-88.
6. Pasel K, Schulz A, Timmermann K, Linnemann K, Hoeltzenbein M, Jaaskelainen J, Gruters A, Filler G and Schoneberg T. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab 2000; 85: 1703-1710.
7. Mulders SM, Bichet DG, Rijss JP, Kamsteeg EJ, Arthus MF, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, van Os CH and Deen PM. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998; 102: 57-66.
8. Morin D, Ala Y and Dumas R. [Hereditary nephrogenic diabetes insipidus]. Arch Pediatr 1995; 2: 560-567.
9. van Lieburg AF, Verdijk MA, Knoers VV, van Essen AJ, Proesmans W, Mallmann R, Monnens LA, van Oost BA, van Os CH and Deen PM. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 1994; 55: 648-652.
10. Hochberg Z, Van Lieburg A, Even L, Brenner B, Lanir N, Van Oost BA and Knoers NV. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab 1997; 82: 686-689.
11. Seibold A, Brabet P, Rosenthal W and Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet 1992; 51: 1078-1083.
12. Morello JP and Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001; 63: 607-630.
13. Sadeghi H, Robertson GL, Bichet DG, Innamorati G and Birnbaumer M. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol Endocrinol 1997; 11: 1806-1813.
14. Morello JP, Salahpour A, Petaja-Repo UE, Laperriere A, Lonergan M, Arthus MF, Nabi IR, Bichet DG and Bouvier M. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry 2001; 40: 6766-6775.
15. Albertazzi E, Zanchetta D, Barbier P, Faranda S, Frattini A, Vezzoni P, Procaccio M, Bettinelli A, Guzzi F, Parenti M and Chini B. Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families. J Am Soc Nephrol 2000; 11: 1033-1043.
16. Schoneberg T, Schulz A, Biebermann H, Gruters A, Grimm T, Hubschmann K, Filler G, Gudermann T and Schultz G. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms. Hum Mutat 1998; 12: 196-205.
17. Seong YM, Park HJ, Seong GH, Choi JY, Yoon SJ, Min BR, Kang S and Rhim H. N-terminal truncation circumvents proteolytic degradation of the human HtrA2/Omi serine protease in Escherichia coli: rapid purification of a proteolytically active HtrA2/Omi. Protein Expr Purif 2004; 33: 200-208.
18. Lee MY, Ajjappala BS, Kim MS, Oh YK and Baek KH. DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. J Cell Biochem 2008; 105: 1420-1429.
19. Moon S, Kim JH, Han JH, Ko SH, Ahn YB, Yang SH and Song KH. Novel compound heterozygous mutations in the fructose-1,6- bisphosphatase gene cause hypoglycemia and lactic acidosis. Metabolism 2010;
20. Innamorati G, Sadeghi H and Birnbaumer M. A fully active nonglycosylated V2 vasopressin receptor. Mol Pharmacol 1996; 50: 467-473.
21. Sadeghi HM, Innamorati G and Birnbaumer M. Maturation of receptor proteins in eukaryotic expression systems. J Recept Signal Transduct Res 1997; 17: 433-445.
22. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P and Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357: 333-335.
23. Schoneberg T, Schulz A, Biebermann H, Hermsdorf T, Rompler H and Sangkuhl K. Mutant Gprotein- coupled receptors as a cause of human diseases. Pharmacol Ther 2004; 104: 173-206.
24. Dong Y, Sheng H, Chen X, Yin J and Su Q. Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus. BMC Genet 2006; 7: 53.
25. Schoneberg T, Yun J, Wenkert D and Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 1996; 15: 1283-1291.
26. Sadeghi HM, Innamorati G and Birnbaumer M. An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol Endocrinol 1997; 11: 706-713.